TAVI May Hold Benefits Over Surgical Aortic Valve Replacement
By HospiMedica International staff writers Posted on 28 Oct 2016 |
A new study suggests that patients with severe aortic stenosis may have more to gain from transfemoral transcatheter aortic valve implantation (TAVI) than surgical replacement.
Researchers at McMaster University (Hamilton, ON, Canada), Jagiellonian University (Krakow, Poland), and other institutions conducted a systematic review of four trials with 3,179 patients and a median follow-up of two years to compare TAVI and surgical replacement of an aortic valve (SAVR) in patients with severe aortic stenosis (most of whom older than 80 years of age) who were at low and intermediate risk of perioperative death (i.e., less than 8%). Two reviewers independently extracted data and assessed risk of bias for outcomes important to the patients, which were selected a priori.
The results revealed that over a median follow-up of two years, transfemoral TAVI was associated with better outcomes than SAVR in terms of mortality, stroke, acute kidney injury (AKI), and bleeding. Among the 1,578 patients undergoing TAVI there were an estimated 30 fewer deaths per 1,000 patients than among the 1,550 undergoing SAVR, while for stroke, AKI, and bleeding, there were 20, 53, and 252 fewer instances (respectively). The occurrence of new-onset atrial fibrillation (AF) was also reduced, with 178 fewer instances. The study was published on September 28, 2016, in BMJ.
“The benefits of transfemoral TAVI over SAVR, and the fact that it is less invasive, are likely to make it more compelling for older patients, such as those aged over 85 years. SAVR, however, performs better than transapical TAVI, which is of interest to patients who are not candidates for transfemoral TAVI,” concluded lead author Reed Siemieniuk, MD, of McMaster, and colleagues. “Younger patients, for whom valve longevity could be extremely important, may be more likely to choose SAVR.”
TAVI involves the percutaneous insertion of a catheter containing a replacement valve through the groin or chest; the new valve is pushed into the correct site, where the surgeon expands it into position. TAVI is an increasingly popular alternative to open surgery, as it does not require thoracotomy or a heart-lung machine. Guidelines recommend both TAVI and SAVR in patients in high surgical risk, but recommend SAVR over TAVI for lower risk patients. But despite this recommendation, half of the TAVI centers in Europe perform TAVI in intermediate risk patients, and 10% of centers do so in low risk patients.
Related Links:
McMaster University
Jagiellonian University
Researchers at McMaster University (Hamilton, ON, Canada), Jagiellonian University (Krakow, Poland), and other institutions conducted a systematic review of four trials with 3,179 patients and a median follow-up of two years to compare TAVI and surgical replacement of an aortic valve (SAVR) in patients with severe aortic stenosis (most of whom older than 80 years of age) who were at low and intermediate risk of perioperative death (i.e., less than 8%). Two reviewers independently extracted data and assessed risk of bias for outcomes important to the patients, which were selected a priori.
The results revealed that over a median follow-up of two years, transfemoral TAVI was associated with better outcomes than SAVR in terms of mortality, stroke, acute kidney injury (AKI), and bleeding. Among the 1,578 patients undergoing TAVI there were an estimated 30 fewer deaths per 1,000 patients than among the 1,550 undergoing SAVR, while for stroke, AKI, and bleeding, there were 20, 53, and 252 fewer instances (respectively). The occurrence of new-onset atrial fibrillation (AF) was also reduced, with 178 fewer instances. The study was published on September 28, 2016, in BMJ.
“The benefits of transfemoral TAVI over SAVR, and the fact that it is less invasive, are likely to make it more compelling for older patients, such as those aged over 85 years. SAVR, however, performs better than transapical TAVI, which is of interest to patients who are not candidates for transfemoral TAVI,” concluded lead author Reed Siemieniuk, MD, of McMaster, and colleagues. “Younger patients, for whom valve longevity could be extremely important, may be more likely to choose SAVR.”
TAVI involves the percutaneous insertion of a catheter containing a replacement valve through the groin or chest; the new valve is pushed into the correct site, where the surgeon expands it into position. TAVI is an increasingly popular alternative to open surgery, as it does not require thoracotomy or a heart-lung machine. Guidelines recommend both TAVI and SAVR in patients in high surgical risk, but recommend SAVR over TAVI for lower risk patients. But despite this recommendation, half of the TAVI centers in Europe perform TAVI in intermediate risk patients, and 10% of centers do so in low risk patients.
Related Links:
McMaster University
Jagiellonian University
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery